Chronic Lymphocytic Leukemia (cll) - Neonatal Disorders

Relevant Publications

A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments.

Issue Release: 2024

Lessons learned from the Eµ-TCL1 mouse model of CLL.

Issue Release: 2024

Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE.

Issue Release: 2024

Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia.

Issue Release: 2024

Spontaneous Regression Accompanied by Concomitant Immune Alterations in a Patient with Chronic Lymphocytic Leukemia.

Issue Release: 2024

Optimization of In Vitro Th17 Polarization for Adoptive Cell Therapy in Chronic Lymphocytic Leukemia.

Issue Release: 2024

Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.

Issue Release: 2024

Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy.

Issue Release: 2024

Serum levels of B-cell activating factor are associated with a reduced risk of chronic lymphocytic leukemia.

Issue Release: 2024

CAR-T Cells in Chronic Lymphocytic Leukemia.

Issue Release: 2024

A rare case of Richter transformation with breast involvement: A case report and literature review.

Issue Release: 2024

Defining treatment success in chronic lymphocytic leukemia: exploring surrogate markers, comorbidities, and patient-centered endpoints.

Issue Release: 2024

Human serum albumin-based drug-free macromolecular therapeutics induce apoptosis in chronic lymphocytic leukemia patient cells by crosslinking of CD20 and/or CD38 receptors.

Issue Release: 2024

Shift in first-line therapies for United States Veterans Affairs (VA) patients with chronic lymphocytic leukemia (CLL).

Issue Release: 2024

Richter Syndrome Presenting as Subcutaneous Nodules and a Dermal Plaque.

Issue Release: 2024

T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.

Issue Release: 2024

Are we closer to a standard of care for Richter\'s syndrome? Novel treatments on the horizon.

Issue Release: 2024

Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry.

Issue Release: 2024

Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice.

Issue Release: 2024

Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management.

Issue Release: 2024

What Causes Mutations in the RB1 Gene?

How are Neonatal Disorders Related to Intellectual Disabilities?

What Causes Bedwetting?

How Do Parenting Styles Influence Child Development?

What is a Reverse Osmosis System?

What is Congenital Scoliosis?

What Resources Can Help Parents Establish a Routine?

What are the Indications for Immunoglobulin Replacement Therapy?

What is the Role of Hypothermia in Resuscitation?

How Common is Miliary TB in Children?

Partnered Content Networks

Relevant Topics